Literature DB >> 14636492

[Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].

J I Jaén Díaz1, C de Castro Mesa, M J Gontán García-Salamanca, F López de Castro.   

Abstract

OBJECTIVE: To estimate the prevalence of chronic obstructive pulmonary disease (COPD) in smokers and ex-smokers over 40 years of age and describe the associated risk factors.
MATERIAL AND METHODS: A cross-sectional descriptive study at primary care level in which 444 current or ex-smokers 40 years of age or older were enrolled. Spirometry was performed with all subjects. If the ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) was less than 70%, a bronchodilator test was performed and spirometry was repeated after 2 inhalations of terbutaline (500 g/dose). If the FEV1/FVC ratio continued to be less than 70% and FEV1 less than 80% of predicted, COPD was diagnosed. Age, sex, smoking, age smoking began, index of smoking history (packs per day x year) and attempts to quit smoking were also recorded.
RESULTS: The patients' mean age was 53.5 years and 65.8% were men. At the time of the study, 248 subjects (55.9%) were current smokers. The median age smoking began was 16.5 years and the median pack-years index was 26.7. At least 1 attempt to quit had been made by 72.1% of the patients. COPD was diagnosed in 70 subjects (24 with the diagnosis previously established), representing a prevalence of 16.4% (95% confidence interval, 12.9-19.9). COPD was serious in 10%. A multifactorial analysis indicated that age and smoking history in pack-years were significantly associated with COPD.
CONCLUSIONS: The prevalence of COPD in our study is slightly higher than in other studies, although selection bias may have affected our results given that we were unable to contact 11.9% of the population sample. Almost two thirds of cases had not been previously diagnosed. Two major risk factors are age and cumulative tobacco consumption.

Entities:  

Mesh:

Year:  2003        PMID: 14636492     DOI: 10.1016/s0300-2896(03)75454-4

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  8 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

2.  [Spirometry as method of screening and intervention in high- risk smokers in primary care].

Authors:  Joan Clotet; Jordi Real; Iñigo Lorente; Araceli Fuentes; Eugeni Paredes; Carmen Ciria
Journal:  Aten Primaria       Date:  2011-11-15       Impact factor: 1.137

3.  The efficacy of spirometry as a screening tool in detection of air flow obstruction.

Authors:  Nabeel Manzar; A Suleman Haque; Bushra Manzar; Muhammad Irfan
Journal:  Open Respir Med J       Date:  2010-09-23

4.  Functional outcomes in patients with chronic obstructive pulmonary disease: a multivariate analysis.

Authors:  Filipe T S Athayde; Danielle S R Vieira; Raquel R Britto; Verônica F Parreira
Journal:  Braz J Phys Ther       Date:  2014 Jan-Feb       Impact factor: 3.377

5.  Gram Years: A Method to Standardize and Quantify Lifetime Cannabis Consumption.

Authors:  Reagan R Wetherill; Nathan Hager; Emily Guthier; Teresa R Franklin
Journal:  Cannabis Cannabinoid Res       Date:  2016-09

6.  The effect of dietary antioxidant on the COPD risk: the community-based KoGES (Ansan-Anseong) cohort.

Authors:  Pankaj Joshi; Woo Jin Kim; Sang-Ah Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-08

7.  Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan.

Authors:  Mousa Al Omari; Basheer Y Khassawneh; Yousef Khader; Ali Shakir Dauod; George Bergus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-07-17

8.  Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California.

Authors:  Hayley J Koslik; Jisha Joshua; Jazmine Cuevas-Mota; Daniel Goba; Eyal Oren; John E Alcaraz; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.